PRECISION EPIGENOMICS, INC.
Tucson, AZ
What changed
NIH P20 · $2.3M · Vermont Center for Cardiovascular and Brain Health
2mo agoGrant renewalMay 18, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 58 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Peer position
11,144 pre-ticker oncology companies at Grant-only
Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.
Compare seatsA ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R44 · $1.0M · non-dilutive
Aug 1, 2024PRECISION EPIGENOMICS, INC. · PI NELSON, MARK ANTHONY · NCI · award ends Jul 31, 2027 · Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
NIH RePORTER · NIH RePORTER 11143911 (opens the source filing in a new tab)
- Grant
R01 · $658k · non-dilutive
Aug 15, 2022UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · NINDS · award ends Jul 31, 2027 · Lesions and Loss of Smooth Muscle Cells in Brain Underlies Small Vessel Disease
NIH RePORTER · NIH RePORTER 10699792 (opens the source filing in a new tab)
- Grant
P20 · $2.3M · non-dilutive
Dec 1, 2020UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CUSHMAN, MARY · NIGMS · award ends Mar 31, 2031 · Vermont Center for Cardiovascular and Brain Health
NIH RePORTER · NIH RePORTER 11335682 (opens the source filing in a new tab)
- Trial
Study registered
Feb 1, 2014CADASIL · COMPLETED · sponsor: Institut National de la Santé Et de la Recherche Médicale, France · Generation of a Cellular Model of CADASIL From Skin Fibroblasts
ClinicalTrials.gov · NCT02032225 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources